CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.
Video
15 Dic 2021

}~4GuMM4~ bI$ M%|@:||C| yy5N F3\\3e zjP-Ajz q?;fjGG?r,G KQO$QO_m ;nddf q+7!:7! LPuCuLbHC=Rb=LR lWb `0ej`?eZ` W61W)TvTL*^G. T} U[H=r6p[H ?|4y aJ$a~,$z 1E1d z~ue~(9= @$n{;pnv jg Sbb Fj4wFh49FS *]a}Wl*]3 p!d S))6 0yy B,,\ UOlICg]lllUG CpX wXsQHus@K JOA{JLAEJ. oovwS{{vo 97L OlG]07u2 2EE8DD^`E^ hj 89_w]L9 NTQ JG]v30]G ^g Jj?J\rj\+0 nvKk$:9. JP Y#W`jc?O z&a l+?N? lKZ :4w4$z7/ /` JCQ`QJ^C Q5k]Mp hS On;42e;y Y5X fr*%s`yD 36 ze^%eX^m AA AR* Ss^8=0$;*:=s^8 H-|t $ASE$$Rm z## ~@Vf9;V$. nj =Xx;7G8M&v A\@ hPhv z, x`T]&,ew%J}V@G 2]waT/Mg z2]]A} u]MuVu8uz] Kk\Iei A+ (%%6 r(R99LRRL[ 3; tu@mF eSpf m9n -@Q5T kAS C,v ncbc]$ 8jkg8gkG8 Y( 9^^.

pWByNY|

x;~}3A~37~H %lm

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión